Tower Research Capital LLC (TRC) - GT BIOPHARMA INC ownership

GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 32 filers reported holding GT BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of GT BIOPHARMA INC
ValueSharesWeighting
Q4 2023$5,043
+3.8%
19,775
-1.9%
0.00%
Q3 2023$4,858
-21.5%
20,158
+1.7%
0.00%
Q2 2023$6,185
+38556.2%
19,823
-30.2%
0.00%
-100.0%
Q1 2023$16
+14.3%
28,415
+84.2%
0.00%0.0%
Q4 2022$14
-99.8%
15,423
+187.0%
0.00%
Q3 2022$9,000
-18.2%
5,374
+45.6%
0.00%
Q2 2022$11,000
+22.2%
3,691
+14.2%
0.00%
Q1 2022$9,000
-25.0%
3,231
-16.9%
0.00%
Q4 2021$12,000
-47.8%
3,888
+13.9%
0.00%
-100.0%
Q3 2021$23,000
+475.0%
3,414
+1141.5%
0.00%
Q2 2021$4,000
-55.6%
275
-79.6%
0.00%
Q1 2021$9,0001,3500.00%
Other shareholders
GT BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Moss Adams Wealth Advisors LLC 20,000$5,1000.00%
WELLS FARGO & COMPANY/MN 300,719$76,6830.00%
JANE STREET GROUP, LLC 19,405$4,9480.00%
NORTHERN TRUST CORP 32,347$8,2480.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 14,605$3,7240.00%
OSAIC HOLDINGS, INC. 1,017$2580.00%
Retirement Group, LLC 44$110.00%
GEODE CAPITAL MANAGEMENT, LLC 337,315$86,0460.00%
MILLENNIUM MANAGEMENT LLC 65,953$16,8180.00%
View complete list of GT BIOPHARMA INC shareholders